MedTrace Logo

AZD Single Ascending Dose Study In Healthy Japanese Subjects

NCT01028040 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2010-12-10

No results posted yet for this study

Summary

This is a single centre, open label, non-randomised study to access the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD3043 following a single dose administration to Japanese subjects.

Conditions

  • Healthy

Interventions

DRUG

AZD3043

Intravenous, single dose

DRUG

AZD3043

Infusion, single dose

Sponsors & Collaborators

Principal Investigators

  • Dr. Ulrike Lorch, MFPM FRCA · Richmond Pharmacology Limited

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01028040 on ClinicalTrials.gov